CRC Research Update — May 12, 2026
Today's colorectal cancer research highlights
precancer
A collection of 138 issues
Five Decades of Familial Adenomatous Polyposis Surveillance in Denmark
Skip to content
The CRC Digest
Five Decades of Familial Adenomatous Polyposis Surveillance in Denmark
A study from the Danish Polyposis Register emphasizes the importance of lifelong endoscopic surveillance and tailored treatment strategies for FAP patients, who face elevated risks for duodenal and pancreatic cancers even after colectomy. (APMIS)
This
Nous-209 Immunotherapy Targets Appear Early in Lynch Syndrome Precancers
Skip to content
The CRC Digest
Nous-209 Immunotherapy Targets Appear Early in Lynch Syndrome Precancers
In a study of Lynch syndrome carriers, 83% of advanced adenomas and 58% of adenomas were mismatch repair-deficient, and the presence of Nous-209 mutations correlated strongly with microsatellite instability status, suggesting potential for preventive immunotherapy.
CRC Research Update — April 20, 2026
Today's colorectal cancer research highlights
CRC Research Update — April 19, 2026
Today's colorectal cancer research highlights
Blood-Based Screening Biomarkers Under Review
Skip to content
The CRC Digest
Blood-Based Screening Biomarkers Under Review
Researchers identified novel blood test candidates that could complement or enhance current colorectal cancer screening approaches. (Clinical Colorectal Cancer)
This content is informational only and does not constitute medical advice.
Always consult your oncologist or care team.
© 2026 The
ctDNA Among Novel Screening Biomarkers
Skip to content
The CRC Digest
ctDNA Among Novel Screening Biomarkers
Systematic review highlights circulating tumor DNA as a candidate for blood-based colorectal cancer screening. (Clinical Colorectal Cancer)
This content is informational only and does not constitute medical advice.
Always consult your oncologist or care team.
© 2026 The CRC Digest
CRC Research Finding
Skip to content
The CRC Digest
▪ Review Identifies Promising Blood-Based Biomarkers for CRC Screening
A systematic review examined novel blood tests, including circulating tumor DNA (ctDNA), that could help detect colorectal cancer and precancerous conditions earlier through less invasive screening methods. (Clinical Colorectal Cancer)
This content is informational only and